Networth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.48K Buy
52
+1
+2% +$27 ﹤0.01% 307
2026
Q2
$1.23K Buy
51
+37
+264% +$968 ﹤0.01% 315
2026
Q1
$393 Hold
14
– – ﹤0.01% 363
2025
Q4
$349 Buy
+14
New +$353 ﹤0.01% 364

Other funds holding PFE

Networth Advisors's PFE Position: Q3 2026 in Review

Networth Advisors increased its Pfizer (PFE) stake by 2% in Q3 2026, buying an estimated $27 and bringing the position to 52 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #307.

Networth Advisors first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Networth Advisors held 52 shares of Pfizer worth $1.48K as of Q3 2026.
  • Networth Advisors bought 1 Pfizer share in Q3 2026, an estimated $27.
  • Pfizer made up ﹤0.01% of Networth Advisors's portfolio in Q3 2026, its #307 holding.
  • Networth Advisors first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
  • 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Networth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.